Close
Back to HZNP Stock Lookup

Horizon Therapeutics (HZNP) – Hot FDA News

Jan 18, 2023 08:03 AM Horizon Therapeutics (HZNP) Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population
May 3, 2022 09:15 AM Horizon Therapeutics (HZNP) Announces Phase 2 Study of Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis
Jan 21, 2020 02:49 PM
Jan 13, 2020 08:25 AM
Dec 13, 2019 04:02 PM
Dec 13, 2019 03:14 PM
Dec 13, 2019 07:01 AM
Feb 28, 2019 07:22 AM
Oct 25, 2017 08:15 AM
Jul 14, 2017 08:08 AM
Jul 26, 2012 04:12 PM

Back to HZNP Stock Lookup